Akaza Research Receives the National Cancer Institute's "Embodying the Vision" Award
Akaza Research has been honored at the National Cancer Institute's caBIG conference with the "Embodying the Vision" award. CAMBRIDGE, MA (PRWEB) March 7, 2007 -- Several members of the Akaza Research team have been named recipients of the National Cancer Institute's caBIG initiative "Embodying the Vision" award. This award is given to individuals and teams that help to achieve the caBIG vision through ongoing actions, multiple program accomplishments, fostering collaboration across workspaces, projects and institutions and other activities that are in alignment with the true spirit and vision of the caBIG initiative. The caBIG™ initiative makes critical tools and data accessible to cancer researchers worldwide to speed the development of innovative approaches for cancer prevention and treatment. The cutting-edge infrastructure developed by caBIG™ has broad utility in other disease areas as well. The Akaza Research development team partnered with Northwestern University and Semantic Bits, LLC to develop a Patient Study Calendar platform for the National Cancer Institute's Cancer Bioinformatics Grid (caBIG™) initiative. Recipients of the award from Akaza were Jaron Sampson, Yufang Wang, Tom Hickerson, Jun Xu, and Cal Collins. Akaza Research has taken substantial steps to make its popular open source clinical trials platform, OpenClinica™, compatible with the caBIG infrastructure. Akaza will be working on integrating the Patient Study Calendar with the OpenClinica® Electronic Data Capture (EDC) for the clinical trials industry. "OpenClinica's compatibility efforts with caBIG means that cancer researchers can obtain a much higher degree of productivity from their research efforts," said Ben Baumann, V.P. of Marketing. About Akaza Research
Akaza Research, a leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based systems accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www.akazaresearch.com. About OpenClinica
OpenClinica™ is an open source web-based software platform that enables sponsors and investigators to manage clinical research data in multi-site studies. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management.
OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. OpenClinica v2.0 was released in November 2006 under the GNU Lesser General Public License (LGPL). See www.OpenClinica.org. ###
Simillar Articles
|
